{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:20:25Z","timestamp":1744777225338,"version":"3.40.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s40264-023-01311-6","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T13:02:12Z","timestamp":1685192532000},"page":"813-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Authors\u2019 Reply to Juergen O Kirchner\u2019s Comment on \u201cIncidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project\u201d"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6310-6019","authenticated-orcid":false,"given":"Corinne","family":"Willame","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Weibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam C. J. M.","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,27]]},"reference":[{"key":"1311_CR1","doi-asserted-by":"publisher","unstructured":"Kirchner J. Comment on \u201cRates of autoimmune diseases in European healthcare databases: a contribution of the ADVANCE project\u201d. Drug Saf. 2023. https:\/\/doi.org\/10.1007\/s40264-023-01310-7","DOI":"10.1007\/s40264-023-01310-7"},{"issue":"Suppl 2","key":"1311_CR2","doi-asserted-by":"publisher","first-page":"B1","DOI":"10.1016\/j.vaccine.2019.07.081","volume":"38","author":"M Sturkenboom","year":"2020","unstructured":"Sturkenboom M, Bahri P, Chiucchiuini A, Grove KT, Hahn\u00e9 S, Khromava A, Kokki M, Kramarz P, Kurz X, Larson HJ, de Lusignan S, Mahy P, Torcel-Pagnon L, Titievsky L, Bauchau V, ADVANCE consortium. Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines. Vaccine. 2020;38(Suppl 2):B1\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.081. (Epub 2019 Oct 31. PMID: 31677952).","journal-title":"Vaccine"},{"issue":"1","key":"1311_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.vaccine.2022.11.031","volume":"41","author":"C Willame","year":"2023","unstructured":"Willame C, Dodd C, Dur\u00e1n CE, Elbers R, Gini R, Bartolini C, Paoletti O, Wang L, Ehrenstein V, Kahlert J, Haug U, Schink T, Diez-Domingo J, Mira-Iglesias A, Carreras JJ, Vergara-Hern\u00e1ndez C, Giaquinto C, Barbieri E, Stona L, Huerta C, Mart\u00edn-P\u00e9rez M, Garc\u00eda-Poza P, de Burgos A, Mart\u00ednez-Gonz\u00e1lez M, Bryant V, Villalobos F, Pallej\u00e0-Mill\u00e1n M, Arag\u00f3n M, Carreras JJ, Souverein P, Thurin NH, Weibel D, Klungel OH, Sturkenboom M. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases\u2014an ACCESS cohort study. Vaccine. 2023;41(1):251\u201362. https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.031. (Epub 2022 Nov22. PMID: 36446653; PMCID: PMC9678835).","journal-title":"Vaccine"},{"issue":"3","key":"1311_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40264-020-01031-1","volume":"44","author":"C Willame","year":"2021","unstructured":"Willame C, Dodd C, van der Aa L, Picelli G, Emborg HD, Kahlert J, Gini R, Huerta C, Mart\u00edn-Merino E, McGee C, de Lusignan S, Roberto G, Villa M, Weibel D, Titievsky L, Sturkenboom MCJM. Incidence rates of autoimmune diseases in European Healthcare Databases: a contribution of the ADVANCE Project. Drug Saf. 2021;44(3):383\u201395. https:\/\/doi.org\/10.1007\/s40264-020-01031-1. (Epub 2021 Jan 19. PMID: 33462778; PMCID:PMC7892524).","journal-title":"Drug Saf"},{"issue":"1","key":"1311_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR, et\u00a0al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166\u201377. https:\/\/doi.org\/10.1002\/ana.25131.","journal-title":"Ann Neurol"},{"key":"1311_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2458-14-111","volume":"14","author":"CH Xiong","year":"2014","unstructured":"Xiong CH, Yan Y, Liao Z, et\u00a0al. Epidemiological characteristics of acute disseminated encephalomyelitis in Nanchang, China\u202f: a retrospective study. BMC Public Health. 2014;14:111.","journal-title":"BMC Public Health"},{"issue":"06","key":"1311_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-0031-1271656","volume":"41","author":"P Pavone","year":"2010","unstructured":"Pavone P, Pettoello-Mantovano M, Pira AL, Giardino L, Pulvirent IA, Giugno R, et\u00a0al. Acute disseminated encephalomyelitis: a long-term prospective study and meta-analysis. Neuropediatrics. 2010;41(06):246\u201355.","journal-title":"Neuropediatrics"},{"key":"1311_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.braindev.2009.10.006","volume":"32","author":"H Torisu","year":"2010","unstructured":"Torisu H, Kira R, Ishizaki Y, et\u00a0al. Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev. 2010;32:454\u201362. https:\/\/doi.org\/10.1016\/j.braindev.2009.10.006.","journal-title":"Brain Dev"},{"key":"1311_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1212\/01.wnI.0000339482.84392.bd","volume":"72","author":"B Banwell","year":"2009","unstructured":"Banwell B, Kennedy J, Sadovnick D, et\u00a0al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology. 2009;72:232\u20139. https:\/\/doi.org\/10.1212\/01.wnI.0000339482.84392.bd.","journal-title":"Neurology"},{"key":"1311_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00431-006-0249-2","volume":"166","author":"D Pohl","year":"2007","unstructured":"Pohl D, Hennemuth L, von Kries R, Hanefeld F. Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. Eur J Pediatr. 2007;166:405\u201312.","journal-title":"Eur J Pediatr"},{"key":"1311_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/01.inf.0000133048.75452.dd","volume":"23","author":"JAD Leake","year":"2004","unstructured":"Leake JAD, Albani S, Kao AS, et\u00a0al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J. 2004;23:756\u201364. https:\/\/doi.org\/10.1097\/01.inf.0000133048.75452.dd.","journal-title":"Pediatr Infect Dis J"},{"key":"1311_CR12","unstructured":"Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (PRAC), Minutes of the meeting on 05-08 July 2021. https:\/\/www.ema.europa.eu\/en\/documents\/minutes\/minutes-prac-meeting-5-8-july-2021_en.pdf. Accessed 23 May 2013."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-023-01311-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:14:15Z","timestamp":1744715655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-023-01311-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,27]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1311"],"URL":"https:\/\/doi.org\/10.1007\/s40264-023-01311-6","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"type":"print","value":"0114-5916"},{"type":"electronic","value":"1179-1942"}],"subject":[],"published":{"date-parts":[[2023,5,27]]},"assertion":[{"value":"17 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Corinne Willame is conducting a Ph.D. at the University Medical Center Utrecht. She works full time for Janssen Pharmaceutica and allocated working time to finalize the submitted work; this should be considered an in-kind contribution. Miriam Sturkenboom and Daniel Weibel are salaried employees by University Medical Center Utrecht, which receives institutional research funding from pharmaceutical companies and regulatory agencies, administered by University Medical Center Utrecht. All these studies follow the ENCePP code of conduct. Miriam Sturkenboom is a consultant to the Task Force for Global Health for the Safety Platform for Emergency vACcines (SPEAC) project.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"All authors contributed equally to the work submitted. All authors read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contribution"}}]}}